Annual CFO
-$27.18 M
NaN%
December 31, 2023
Summary
- As of February 7, 2025, RAPP annual cash flow from operations is -$27.18 million
- RAPP annual CFO is now at all-time high.
Performance
RAPP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$16.41 M
-$63.00 K-0.39%
September 30, 2024
Summary
- As of February 7, 2025, RAPP quarterly cash flow from operations is -$16.41 million, with the most recent change of -$63.00 thousand (-0.39%) on September 30, 2024.
- Over the past year, RAPP quarterly CFO has increased by +$1.20 million (+6.81%).
- RAPP quarterly CFO is now -241.91% below its all-time high of -$4.80 million, reached on March 31, 2023.
Performance
RAPP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$60.74 M
-$10.99 M-22.09%
September 30, 2024
Summary
- As of February 7, 2025, RAPP TTM cash flow from operations is -$60.74 million, with the most recent change of -$10.99 million (-22.09%) on September 30, 2024.
- Over the past year, RAPP TTM CFO has dropped by -$20.74 million (-51.87%).
- RAPP TTM CFO is now -1165.13% below its all-time high of -$4.80 million, reached on March 31, 2023.
Performance
RAPP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RAPP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +6.8% | -51.9% |
| 3 y3 years | - | -241.9% | -1165.1% |
| 5 y5 years | - | -241.9% | -1165.1% |
RAPP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -241.9% | +6.8% | -1165.1% | at low |
| 5 y | 5-year | at high | at low | -241.9% | +6.8% | -1165.1% | at low |
| alltime | all time | at high | at low | -241.9% | +6.8% | -1165.1% | at low |
Rapport Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.41 M(+0.4%) | -$60.74 M(+22.1%) |
| Jun 2024 | - | -$16.35 M(-7.2%) | -$49.75 M(+24.4%) |
| Mar 2024 | - | -$17.61 M(+70.1%) | -$39.99 M(+47.1%) |
| Dec 2023 | -$27.18 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | -$10.36 M(+90.9%) | -$27.18 M(+61.6%) |
| Sep 2023 | - | -$5.42 M(-17.8%) | -$16.82 M(+47.6%) |
| Jun 2023 | - | -$6.60 M(+37.5%) | -$11.40 M(+137.5%) |
| Mar 2023 | - | -$4.80 M | -$4.80 M |
FAQ
- What is Rapport Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly CFO year-on-year change?
- What is Rapport Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Rapport Therapeutics?
- What is Rapport Therapeutics TTM CFO year-on-year change?
What is Rapport Therapeutics annual cash flow from operations?
The current annual CFO of RAPP is -$27.18 M
What is the all time high annual CFO for Rapport Therapeutics?
Rapport Therapeutics all-time high annual cash flow from operations is -$27.18 M
What is Rapport Therapeutics quarterly cash flow from operations?
The current quarterly CFO of RAPP is -$16.41 M
What is the all time high quarterly CFO for Rapport Therapeutics?
Rapport Therapeutics all-time high quarterly cash flow from operations is -$4.80 M
What is Rapport Therapeutics quarterly CFO year-on-year change?
Over the past year, RAPP quarterly cash flow from operations has changed by +$1.20 M (+6.81%)
What is Rapport Therapeutics TTM cash flow from operations?
The current TTM CFO of RAPP is -$60.74 M
What is the all time high TTM CFO for Rapport Therapeutics?
Rapport Therapeutics all-time high TTM cash flow from operations is -$4.80 M
What is Rapport Therapeutics TTM CFO year-on-year change?
Over the past year, RAPP TTM cash flow from operations has changed by -$20.74 M (-51.87%)